EUVIMEDEUVIMED entdecken
Multizentrische Studie

A clinical investigation of a new gelling fibre dressing containing silver for the management of venous leg ulcers

John McRobert, Malene Høj Outzen, Charlotte Hindsberger, Kristine Gjødsbøl, Johanne Louise Gotfredsen, Debera Drew

Journal of Wound Care · 2025

DOI: 10.12968/jowc.2025.0486 ↗

Kurz gefasst

Multizentrische Studie in der Zeitschrift Journal of Wound Care, 2025. Verfasst von John McRobert und 5 weiteren Autor:innen. Beteiligte Einrichtung: Pioneer Wound Healing and Lymphoedema Centres, Crawley, UK. Hauptthemen laut MEDLINE: Varicose Ulcer, Silver, Bandages. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 17 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Objective

To evaluate the performance and safety of Biatain Fiber Ag (Coloplast A/S, Denmark), a new gelling fibre wound dressing containing silver, in venous leg ulcers (VLUs) after four weeks of treatment.

Method

This non-comparative, one-armed, open-labelled study included patients from two sites (clinics or community nursing caseloads) in the UK between February and May 2024. The primary endpoint was relative wound area reduction (WAR) after four weeks of treatment. Adverse events (AEs) were also assessed.

Results

In total, 50 patients with VLUs either infected or at risk of infection, and with medium-to-high levels of exudate, were included in the intention-to-treat (ITT) population. Of these, 45 patients completed the investigation on treatment and five patients discontinued the treatment. In the primary analysis, the estimated mean relative WAR after four weeks was 46.3% (95% confidence interval (CI): 36.5, 56.2%) in the full analysis set (n=49). In the sensitivity analysis based on the ITT population, it was 43.9% (95% CI: 33.1, 54.7%). In total, three AEs were found to be related to the investigational device; all were non-serious.

Conclusion

In this study, treatment of VLUs with the investigational device showed that the mean relative WAR after four weeks of treatment was 46.3%. This reduction in wound area is comparable to the performance of other silver-containing wound dressings. In addition, the results of this clinical investigation revealed no safety concerns. Thus, the study demonstrated that the investigational device is both a safe dressing and one that performs as intended to facilitate VLU healing.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Varicose UlcerSilverBandagesHumansMaleFemaleAgedWound HealingAged, 80 and overGelsMiddle AgedUnited Kingdom

Stichwörter der Autor:innen

antimicrobial dressingchronic woundexudategelling fibre wound dressing containing silverhard-to-healinfectionvenous leg ulcerswoundwound area reductionwound carewound dressingwound healing

Substanzen

SilverGels

Autor:innen und Institutionen

  • Pioneer Wound Healing and Lymphoedema Centres, Crawley, UK.
  • Coloplast A/S, Humlebaek, Denmark.
  • Community Research Team, Northumbria Healthcare NHS Foundation Trust, Ashington, UK.

Zitieren

APA

McRobert, J., Outzen, M. H., Hindsberger, C., Gjødsbøl, K., Gotfredsen, J. L., & Drew, D. (2025). A clinical investigation of a new gelling fibre dressing containing silver for the management of venous leg ulcers. Journal of Wound Care. https://doi.org/10.12968/jowc.2025.0486

Vancouver

McRobert J, Outzen MH, Hindsberger C, Gjødsbøl K, Gotfredsen JL, Drew D. A clinical investigation of a new gelling fibre dressing containing silver for the management of venous leg ulcers. Journal of Wound Care. 2025. doi:10.12968/jowc.2025.0486

BibTeX
@article{McRobert2025,
  author = {McRobert, John and Outzen, Malene Høj and Hindsberger, Charlotte and Gjødsbøl, Kristine and Gotfredsen, Johanne Louise and Drew, Debera},
  title = {A clinical investigation of a new gelling fibre dressing containing silver for the management of venous leg ulcers},
  journal = {Journal of Wound Care},
  year = {2025},
  doi = {10.12968/jowc.2025.0486}
}
Kostenlos starten →